GCK regulates the M1/M2 balance of macrophages through the GR-HADHB-FAO axis, thereby alleviating UC. This study reveals for the first time a novel mechanism by which GCK regulates macrophage polarization through metabolic reprogramming, offering a new potential therapeutic target and candidate drug for the clinical treatment of UC.
Liu et al. (Wed,) studied this question.